Morgan Stanley upgraded Takeda (TAK) to Overweight from Equal Weight with a price target of 5,500 yen, up from 4,300 yen. The company does not ...

Iovance Biotherapeutics (NASDAQ:IOVA) versus Qiagen (NYSE:QGEN) (dailypolitical.com) — Iovance Biotherapeutics, headquartered ...

News we're reading • Sheriff bought soft-serve ice cream machines for jail employees (story includes correction) (padailypost ...

The approval of LIVMARLI in Japan marks a significant milestone for patients suffering from these rare cholestatic liver diseases. ALGS and PFIC are genetic disorders that can cause severe itching and ...

Mirum Pharmaceuticals (MIRM) announced that its partner, Takeda (TAK), has received approval by the Japanese Ministry of Health, Labour, and ...

WITHit ( the leader in innovative wearable tech accessories, is welcoming spring with a bold new collection of Apple Watch bands and cases. Designed for comfort and versatility, these accessories ...

Thermo Fisher Scientific Inc., the world leader in serving science, has announced a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biological Imaging (CZ Imaging ...

LIVMARLI is the first and only treatment available for cholestatic pruritus in patients with Alagille syndrome and Progressive Familial Intrahepatic Cholestasis in Japan “We are thrilled to see ...